Alpha Cognition to Present at the Planet MicroCap Showcase: VEGAS 2023 on Wednesday, April 26, 2023 & 1x1 Meetings on Thursday, April 27, 2023
Alpha Cognition to Present at the Planet MicroCap Showcase: VEGAS 2023 on Wednesday, April 26, 2023 & 1x1 Meetings on Thursday, April 27, 2023
VANCOUVER, BC / ACCESSWIRE / April 5, 2023 / Alpha Cognition Inc. (TSX-V:ACOG)(OTCQB:ACOGF), a biopharmaceutical company developing novel therapies for debilitating neurodegenerative disorders, today announced that it will be presenting at the Planet MicroCap Showcase: VEGAS 2023 on Wednesday, April 26, 2023 at 10:30AM (Local Time -PST). Michael McFadden, CEO of Alpha Cognition, will be hosting the presentation and answering questions at the conclusion.
溫哥華，卑詩省/ACCESSWIRE/2023年4月5日/Alpha Cognition Inc.(多倫多證券交易所股票代碼：ACOG)(多倫多證券交易所股票代碼：ACOG)(OTCQB：ACOGF)是一家為衰弱的神經退行性疾病開發新療法的生物製藥公司，該公司今天宣佈，它將於2023年4月26日星期三上午10：30(當地時間-太平洋標準時間)在Planet MicroCap Showcase：拉斯維加斯2023上展出。Alpha Cognition首席執行官邁克爾·麥克法登將主持演示並在總結時回答問題。
To access the live presentation, please use the following information:
要收看現場演示，請使用以下資訊：
Planet MicroCap Showcase: VEGAS 2023
Date: Wednesday, April 26th, 2023
Time: 1:30 PM Eastern Time (10:30 AM Pacific Time)
Webcast:
Planet MicroCap展示會：維加斯2023
日期：2023年4月26日，星期三
時間：東部時間下午1：30(太平洋時間上午10：30)
網路直播：
If you would like to book 1x1 investor meetings with Alpha Cognition, and to attend the Planet MicroCap Showcase: VEGAS 2023, please make sure you are registered here:
如果您想預訂Alpha Cognition的1x1投資者會議，並參加Planet MicroCap Showcase：拉斯維加斯2023，請確保您在此處註冊：
1x1 meetings will be scheduled and conducted in person at the conference venue in LAS VEGAS.
1x1會議將在拉斯維加斯的會議場地安排和親自舉行。
The Planet MicroCap Showcase: VEGAS 2023 website is available here:
Planet MicroCap Showcase：拉斯維加斯2023網站可在此處獲得：
If you can't make the live presentation, all company presentations "webcasts" will be available directly on the conference event platform on this link under the tab "Agenda":
如果您無法進行現場演示，所有公司演示文稿的網路直播將直接在會議活動平臺上的此鏈接上的“議程”選項卡下提供：
News Compliments of Accesswire
恭維的新聞附件線
About Alpha Cognition
關於阿爾法認知
Alpha Cognition Inc. is a clinical stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease and Amyotrophic Lateral Sclerosis (ALS), for which there are limited treatment options.
阿爾法認知公司是一家臨床階段的生物製藥公司，致力於為患有神經退行性疾病的患者開發治療方法，例如阿爾茨海默病和肌萎縮側索硬化症(ALS)，這些疾病的治療選擇有限。
ALPHA-1062, is a patented new chemical entity being developed as a new generation acetylcholinesterase inhibitor for the treatment of Alzheimer's disease, with expected minimal gastrointestinal side effects. ALPHA-1062's active metabolite is differentiated from donepezil and rivastigmine in that it binds neuronal nicotinic receptors, most notably the alpha-7 subtype, which is known to have a positive effect on cognition. ALPHA-1062 is also being developed in combination with memantine to treat moderate to severe Alzheimer's dementia, and as an intranasal formulation for traumatic brain injury.
Alpha-1062是一種獲得專利的新化學實體，正在作為新一代乙酰膽鹼酯酵素抑制劑開發，用於治療阿爾茨海默病，預計胃腸道副作用最小。阿爾法-1062的活性代謝物與多奈哌齊和利瓦斯明的不同之處在於它與神經元尼古丁受體結合，最著名的是阿爾法-7亞型，這是已知對認知有積極影響的亞型。阿爾法-1062也正在與美金剛聯合開發，用於治療中到重度阿爾茨海默氏症，並作為創傷性腦損傷的鼻內制劑。
About Planet MicroCap
關於Planet MicroCap
Planet MicroCap is a global multimedia financial news, publishing and events company focused on news dissemination, providing information, data and analytics for the MicroCap investing community. We have cultivated an active and engaged audience of folks that are interested in learning about and to stay ahead of the curve in the MicroCap space.
Planet MicroCap是一家專注於新聞傳播的全球性多媒體金融新聞、出版和活動公司，為MicroCap投資界提供資訊、數據和分析。我們培養了一批積極參與的受眾，他們有興趣瞭解並保持在MicroCap領域的領先地位。
If you would like to attend the Planet MicroCap Showcase, please register here:
如果您想參加Planet MicroCap展示會，請在此處註冊：
Contact:
info@alphacognition.com
聯繫方式：
郵箱：Info@alphacognition.com
SOURCE: Alpha Cognitionvia SNN Network
資料來源：基於SNN網路的Alpha認知
譯文內容由第三人軟體翻譯。